» Articles » PMID: 16533814

Deoxyhypusine Hydroxylase is a Fe(II)-dependent, HEAT-repeat Enzyme. Identification of Amino Acid Residues Critical for Fe(II) Binding and Catalysis [corrected]

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Mar 15
PMID 16533814
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Deoxyhypusine hydroxylase (DOHH) catalyzes the final step in the post-translational synthesis of hypusine (N(epsilon)-(4-amino-2-hydroxybutyl)lysine) in eIF5A. DOHH is a HEAT-repeat protein with eight tandem helical hairpins in a symmetrical dyad. It contains two potential iron coordination sites (one on each dyad) composed of two strictly conserved His-Glu motifs. The purified human recombinant DOHH was a mixture of active holoenzyme containing 2 mol of iron/mol of DOHH and inactive metal-free apoenzyme. The two species could be distinguished by their different mobilities upon native gel electrophoresis. The DOHH apoenzyme exhibited markedly reduced levels of iron and activity. DOHH activity could be restored only by the addition of Fe2+ to the apoenzyme but not by other metals including Cd2+,Co2+,Cr2+,Cu2+,Mg2+,Mn2+,Ni2+, and Zn2+. The role of the strictly conserved His-Glu residues was evaluated by site-directed mutagenesis. Substitution of any single amino acid in the four His-Glu motifs with alanine abolished the enzyme activity. Of these eight alanine substitutions, six, including H56A, H89A, E90A, H207A, H240A, and E241A, caused a severe reduction in the iron content. Our results provide strong evidence that Fe(II) is the active-site-bound metal critical for DOHH catalysis and that the strictly conserved His-Glu motifs are essential for iron binding and catalysis. Furthermore, the iron to DOHH stoichiometry and dependence of iron binding on each of the four conserved His-Glu motifs suggest a binuclear iron mediated reaction mechanism, distinct from that of other Fe(II)-dependent protein hydroxylases, such as prolyl 4-hydroxylase or lysyl hydroxylases.

Citing Articles

ERK1/2 interaction with DHPS regulates eIF5A deoxyhypusination independently of ERK kinase activity.

Becker A, Kochanowski P, Wu P, Wator E, Chen W, Guchhait K Cell Rep. 2024; 43(10):114831.

PMID: 39392755 PMC: 11544350. DOI: 10.1016/j.celrep.2024.114831.


Construction of iron metabolism-related prognostic features of gastric cancer based on RNA sequencing and TCGA database.

Liu X, Ren J, Zhou R, Wen Z, Wen Z, Chen Z BMC Cancer. 2023; 23(1):1106.

PMID: 37957566 PMC: 10644585. DOI: 10.1186/s12885-023-11569-9.


Free Radical and Viral Infection: A Review from the Perspective of Ferroptosis.

Chen J, Fu J, Zhao S, Zhang X, Chao Y, Pan Q Vet Sci. 2023; 10(7).

PMID: 37505861 PMC: 10384322. DOI: 10.3390/vetsci10070456.


Cryo-EM structure of human eIF5A-DHS complex reveals the molecular basis of hypusination-associated neurodegenerative disorders.

Wator E, Wilk P, Biela A, Rawski M, Zak K, Steinchen W Nat Commun. 2023; 14(1):1698.

PMID: 36973244 PMC: 10042821. DOI: 10.1038/s41467-023-37305-2.


Bi-allelic variants in DOHH, catalyzing the last step of hypusine biosynthesis, are associated with a neurodevelopmental disorder.

Ziegler A, Steindl K, Hanner A, Kar R, Prouteau C, Boland A Am J Hum Genet. 2022; 109(8):1549-1558.

PMID: 35858628 PMC: 9388783. DOI: 10.1016/j.ajhg.2022.06.010.


References
1.
Spradling A, Stern D, Beaton A, Rhem E, Laverty T, Mozden N . The Berkeley Drosophila Genome Project gene disruption project: Single P-element insertions mutating 25% of vital Drosophila genes. Genetics. 1999; 153(1):135-77. PMC: 1460730. DOI: 10.1093/genetics/153.1.135. View

2.
Andrade M, Petosa C, ODonoghue S, Muller C, Bork P . Comparison of ARM and HEAT protein repeats. J Mol Biol. 2001; 309(1):1-18. DOI: 10.1006/jmbi.2001.4624. View

3.
Park J, Aravind L, Wolff E, Kaevel J, Kim Y, Park M . Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme. Proc Natl Acad Sci U S A. 2005; 103(1):51-6. PMC: 1324997. DOI: 10.1073/pnas.0509348102. View

4.
Bevec D, HAUBER J . Eukaryotic initiation factor 5A activity and HIV-1 Rev function. Biol Signals. 1997; 6(3):124-33. DOI: 10.1159/000109118. View

5.
Hanauske-Abel H, Popowicz A . The HAG mechanism: a molecular rationale for the therapeutic application of iron chelators in human diseases involving the 2-oxoacid utilizing dioxygenases. Curr Med Chem. 2003; 10(12):1005-19. DOI: 10.2174/0929867033457601. View